Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-16-005291
Filing Date
2016-08-22
Accepted
2016-08-22 16:01:53
Documents
70
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q biostarpharma10q063016.htm 10-Q 1032832
2 EX-31.1 ex31-1.htm EX-31.1 14145
3 EX-31.2 ex31-2.htm EX-31.2 14338
4 EX-32.1 ex32-1.htm EX-32.1 5805
5 EX-32.2 ex32-2.htm EX-32.2 5739
  Complete submission text file 0001185185-16-005291.txt   4824327

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bspm-20160630.xml EX-101.INS 1007432
7 XBRL TAXONOMY EXTENSION SCHEMA bspm-20160630.xsd EX-101.SCH 50702
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bspm-20160630_cal.xml EX-101.CAL 35863
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bspm-20160630_def.xml EX-101.DEF 235926
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bspm-20160630_lab.xml EX-101.LAB 297586
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bspm-20160630_pre.xml EX-101.PRE 239026
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 161845322
SIC: 2834 Pharmaceutical Preparations